Latest filing published 02 Mar 2026 for Rhythm Pharmaceuticals, INC., €35k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Hunter C. Smith span 2 companies, the busiest being Rhythm Pharmaceuticals, Inc. and Genesee & Wyoming Inc. In total, 109 filings cover trades dated from 31 March 2015 to 2 March 2026.
On the market, this insider has only sold: 49 sales, €11.2M in total. The rest of the record consists of 26 share grants and 32 option exercises. Since January 2026: no purchases and 23 sales on the market.
The newest entry dates from 2 March 2026: an option exercise of €35k, in Rhythm Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 29 declarations